Order Article Reprints

Dubinsky MC, Rabizadeh S, Panetta JC, Spencer EA, Everts-van der Wind A, Dervieux T. The Combination of Predictive Factors of Pharmacokinetic Origin Associates with Enhanced Disease Control during Treatment of Pediatric Crohn’s Disease with Infliximab. Pharmaceutics. 2023; 15(10):2408. https://doi.org/10.3390/pharmaceutics15102408

Dubinsky, Marla C., Shervin Rabizadeh, John C. Panetta, Elizabeth A. Spencer, Annelie Everts-van der Wind, and Thierry Dervieux. 2023. "The Combination of Predictive Factors of Pharmacokinetic Origin Associates with Enhanced Disease Control during Treatment of Pediatric Crohn’s Disease with Infliximab" Pharmaceutics 15, no. 10: 2408. https://doi.org/10.3390/pharmaceutics15102408

Dubinsky, M. C., Rabizadeh, S., Panetta, J. C., Spencer, E. A., Everts-van der Wind, A., & Dervieux, T. (2023). The Combination of Predictive Factors of Pharmacokinetic Origin Associates with Enhanced Disease Control during Treatment of Pediatric Crohn’s Disease with Infliximab. Pharmaceutics, 15(10), 2408. https://doi.org/10.3390/pharmaceutics15102408